Table 1.
Hepatitis C virus cohorts.
| Baseline characteristics | Acute HCV | Chronic HCV non-cirrhosis | Chronic HCV cirrhosis |
|---|---|---|---|
| Number of patients | 29 | 23 | 31 |
| Sex (f/m) | 6/23 | 12/11 | 0/31 |
| Median age (min–max) | 45 (23–63) | 56 (18–82) | 56 (41/72) |
| Median BMI (min–max) | 23.3 (19–27.7) | 25 (17.6–37) | 28.1 (25.5–36.2) |
| Median quantitative HCV RNA | 42,700 (1,470–8,000,000) | 2,569,350 (55,000–11,000,000) | 1,292,575 (235–7,400,000) |
| Median thrombocytes in Tsd/µl (min–max) | 232 (167–362) | 209 (101–338) | 104 (42–224) |
| Median hemoglobin in g/dL (min–max) | 15.0 (13.6–16.1) | 14.7 (10.3–16.8) | 14.3 (10.3–16.9) |
| Median AST in U/L (min–max) | 46 (27–139) | 111 (15–319) | |
| Median ALT in U/L (min–max) | 222 (38–1494) | 62 (16–183) | 101 (15–284) |
| Median albumin in g/L (min–max) | 42 (35–48) | 36 (26–44) | |
| Median leukocytes in Tsd/µL (min–max) | 6.5 (4–9.9) | 5.2 (2.6–7.5) |